» Articles » PMID: 21441610

Differences Between Human Wild-type and C23S Variant 5-HT2C Receptors in Inverse Agonist-induced Resensitization

Overview
Journal Pharmacol Rep
Specialty Pharmacology
Date 2011 Mar 29
PMID 21441610
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to analyze functional properties of the naturally occurring C23S variant of the human 5-HT2C receptor. In HEK293 cells transiently expressing the unedited forms of the variant receptor (VR) or the wild-type receptor (WTR), surface expression was determined by [3H]mesulergine binding to membrane fragments. Function was examined by an aequorin luminescence-based Ca2+ assay. Surface expression of the VR was 116% of that of the WTR. The 5-HT-induced increase in cytosolic Ca2+ ([Ca2+]i), and its inhibition by the inverse agonist SB 206553 did not differ between VR- or WTR-expressing cells. Preexposure of VR- or WTR-expressing cells to 0.5 μM 5-HT (3 min-4.5 h) led to a practically identical time course and extent in the reduction of the 5-HT-induced increase in [Ca2+]i. In contrast, prolonged preexposure to the inverse agonist SB 206553 (1 μM) elevated the 5-HT-induced increase in [Ca2+]i for both isoreceptors. A preexposure time of 4.5 h was necessary to significantly elevate the Ca2+ response of the WTR, but the VR produced this elevation within 1 h with virtually no further effect after 4.5 h of preexposure. In conclusion, prolonged preexposure to 5-HT caused equally rapid and strong desensitization of both isoreceptors. The different time course of SB 206553-induced resensitization of the two isoreceptors might be therapeutically relevant for drugs exhibiting inverse agonist properties at 5-HT2C receptors, such as atypical antipsychotics and certain antidepressants.

Citing Articles

Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Bonisch H, Fink K, Malinowska B, Molderings G, Schlicker E Naunyn Schmiedebergs Arch Pharmacol. 2021; 394(9):1829-1867.

PMID: 33991216 PMC: 8376721. DOI: 10.1007/s00210-021-02083-5.


International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.

Barnes N, Ahern G, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S Pharmacol Rev. 2020; 73(1):310-520.

PMID: 33370241 PMC: 7770494. DOI: 10.1124/pr.118.015552.


Serotonin 5-HT Receptor Cys23Ser Single Nucleotide Polymorphism Associates with Receptor Function and Localization In Vitro.

Land M, Chapman H, Davis-Reyes B, Felsing D, Allen J, Moeller F Sci Rep. 2019; 9(1):16737.

PMID: 31723224 PMC: 6853916. DOI: 10.1038/s41598-019-53124-2.


Association of Serotonin Receptor Polymorphisms With Antipsychotic Drug Response in Schizophrenia.

Li J, Hashimoto H, Meltzer H Front Psychiatry. 2019; 10:58.

PMID: 30828307 PMC: 6384235. DOI: 10.3389/fpsyt.2019.00058.


The activity of the serotonin receptor 2C is regulated by alternative splicing.

Stamm S, Gruber S, Rabchevsky A, Emeson R Hum Genet. 2017; 136(9):1079-1091.

PMID: 28664341 PMC: 5873585. DOI: 10.1007/s00439-017-1826-3.